PET imaging of inflammation in atherosclerosis

[1]  M. Dweck,et al.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial , 2014, The Lancet.

[2]  V. Fuster,et al.  Noninvasive Assessment of Hypoxia in Rabbit Advanced Atherosclerosis Using 18F-fluoromisonidazole Positron Emission Tomographic Imaging , 2014, Circulation. Cardiovascular imaging.

[3]  M. Schwaiger,et al.  PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. , 2014, JACC. Cardiovascular imaging.

[4]  V. Fuster,et al.  Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Sungeun Kim,et al.  Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by 18F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging , 2014, Circulation. Cardiovascular imaging.

[6]  Yanmei Xu,et al.  Platelet Aggregation Unchanged by Lipoprotein-Associated Phospholipase A2 Inhibition: Results from an In Vitro Study and Two Randomized Phase I Trials , 2014, PloS one.

[7]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[8]  V. Fuster,et al.  Arterial and fat tissue inflammation are highly correlated : a prospective 18F-FDG PET/CT study , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Z. Fayad,et al.  Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. , 2014, Journal of the American College of Cardiology.

[10]  Osamu Okazaki,et al.  Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis , 2014, EJNMMI Research.

[11]  J. H. Rudd,et al.  High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. , 2013, Journal of the American College of Cardiology.

[12]  T. Brady,et al.  Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. , 2013, JACC. Cardiovascular imaging.

[13]  Kyung-Han Lee,et al.  Relation of Carotid Artery 18F-FDG Uptake to C-Reactive Protein and Framingham Risk Score in a Large Cohort of Asymptomatic Adults , 2013, The Journal of Nuclear Medicine.

[14]  F. Jaffer,et al.  The advancing clinical impact of molecular imaging in CVD. , 2013, JACC. Cardiovascular imaging.

[15]  V. Fuster,et al.  The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: rationale and design. , 2013, American heart journal.

[16]  J. Shalhoub,et al.  Clinical assessment of carotid atherosclerosis inflammation by positron emission tomography. , 2013, Current molecular medicine.

[17]  E. Warburton,et al.  Abstract 14673: Imaging of Hypoxia and Inflammation in Carotid Atherosclerosis With 18F-Fluoromisonidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography , 2013 .

[18]  S Stute,et al.  Partial volume effect estimation and correction in the aortic vascular wall in PET imaging , 2013, Physics in medicine and biology.

[19]  A. Zernecke,et al.  Molecular Imaging of Inflammation in Atherosclerosis , 2013, Theranostics.

[20]  H. Griffiths,et al.  Monocytes in coronary artery disease and atherosclerosis: where are we now? , 2013, Journal of the American College of Cardiology.

[21]  M. Daemen,et al.  Hypoxia in atherosclerosis and inflammation , 2013, Current opinion in lipidology.

[22]  H. Sillesen,et al.  (18)F-FDG imaging of human atherosclerotic carotid plaques reflects gene expression of the key hypoxia marker HIF-1α. , 2013, American journal of nuclear medicine and molecular imaging.

[23]  Z. Fayad,et al.  Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. , 2013, Journal of the American College of Cardiology.

[24]  Reto Asmis,et al.  Bioenergetic Profiles Diverge During Macrophage Polarization: Implications for the Interpretation of 18F-FDG PET Imaging of Atherosclerosis , 2013, The Journal of Nuclear Medicine.

[25]  M. Goddard,et al.  Atherosclerotic Plaque Composition and Classification Identified by Coronary Computed Tomography: Assessment of Computed Tomography–Generated Plaque Maps Compared With Virtual Histology Intravascular Ultrasound and Histology , 2013, Circulation. Cardiovascular imaging.

[26]  J. S. Lee,et al.  Feasibility and kinetic characteristics of 68Ga-NOTA-RGD PET for in vivo atherosclerosis imaging , 2013, Annals of Nuclear Medicine.

[27]  P. Libby,et al.  Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. , 2013, American heart journal.

[28]  Y. Magata,et al.  Comparison of Contrast Agents for Atherosclerosis Imaging Using Cultured Macrophages: FDG Versus Ultrasmall Superparamagnetic Iron Oxide , 2013, The Journal of Nuclear Medicine.

[29]  A. Buck,et al.  Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. , 2013, Atherosclerosis.

[30]  Valentino Bettinardi,et al.  Generation of 4-Dimensional CT Images Based on 4-Dimensional PET–Derived Motion Fields , 2013, The Journal of Nuclear Medicine.

[31]  Katsuya Yoshida,et al.  Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects , 2013, Annals of Nuclear Medicine.

[32]  V. Fuster,et al.  Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. , 2013, Journal of the American College of Cardiology.

[33]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[34]  Markus Abt,et al.  Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[35]  J. H. Rudd,et al.  Anti-Tumor Necrosis Factor-&agr; Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis , 2012, Circulation.

[36]  Ramon Luengo-Fernandez,et al.  European Cardiovascular Disease Statistics 2017 , 2012 .

[37]  J. Tardif,et al.  Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see , 2012, Journal of Nuclear Cardiology.

[38]  A. Buck,et al.  68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors , 2012, EJNMMI Research.

[39]  J. H. Rudd,et al.  Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. , 2012, JACC. Cardiovascular imaging.

[40]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[41]  Z. Fayad,et al.  Molecular Imaging in Atherosclerosis: FDG PET , 2012, Current Atherosclerosis Reports.

[42]  A. Davies,et al.  Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. , 2012, European heart journal.

[43]  P. Libby,et al.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. , 2012, Circulation research.

[44]  Oliver Gaemperli,et al.  Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. , 2012, European heart journal.

[45]  H. Sillesen,et al.  Microvessel Density But Not Neoangiogenesis Is Associated with 18F-FDG Uptake in Human Atherosclerotic Carotid Plaques , 2012, Molecular Imaging and Biology.

[46]  Charles P. Lin,et al.  Myocardial infarction accelerates atherosclerosis , 2012, Nature.

[47]  T. Werner,et al.  Relation between popliteal-tibial artery atherosclerosis and global glycolytic metabolism in the affected diabetic foot: a pilot study using quantitative FDG-PET. , 2012, Journal of the American Podiatric Medical Association.

[48]  E. Tuzcu,et al.  Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. , 2012, Journal of the American College of Cardiology.

[49]  E. Dolan,et al.  Carotid plaque inflammation on 18F‐fluorodeoxyglucose positron emission tomography predicts early stroke recurrence , 2012, Annals of neurology.

[50]  D. Dey,et al.  Coronary Arterial 18F-FDG Uptake by Fusion of PET and Coronary CT Angiography at Sites of Percutaneous Stenting for Acute Myocardial Infarction and Stable Coronary Artery Disease , 2012, The Journal of Nuclear Medicine.

[51]  M. D. de Winther,et al.  Molecular Pathways Regulating Macrophage Polarization: Implications for Atherosclerosis , 2012, Current Atherosclerosis Reports.

[52]  Yen-Hung Lin,et al.  The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[53]  E. Galkina,et al.  Phenotypic and Functional Heterogeneity of Macrophages and Dendritic Cell Subsets in the Healthy and Atherosclerosis-Prone Aorta , 2012, Front. Physio..

[54]  R. Virmani,et al.  Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. , 2012, Journal of the American College of Cardiology.

[55]  R. Cury,et al.  Distribution of Inflammation Within Carotid Atherosclerotic Plaques With High-Risk Morphological Features: A Comparison Between Positron Emission Tomography Activity, Plaque Morphology, and Histopathology , 2012, Circulation. Cardiovascular imaging.

[56]  Y. Magata,et al.  What Can Be Seen by 18F-FDG PET in Atherosclerosis Imaging? The Effect of Foam Cell Formation on 18F-FDG Uptake to Macrophages In Vitro , 2012, The Journal of Nuclear Medicine.

[57]  V. Andrés,et al.  A glimpse on the phenomenon of macrophage polarization during atherosclerosis. , 2011, Immunobiology.

[58]  Ahmed Tawakol,et al.  Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.

[59]  R. Dierckx,et al.  High-resolution imaging of human atherosclerotic carotid plaques with micro18F-FDG PET scanning exploring plaque vulnerability , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[60]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[61]  P. Libby,et al.  Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). , 2011, American heart journal.

[62]  P. Libby,et al.  Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. , 2011, Journal of the American College of Cardiology.

[63]  Toby Richards,et al.  Investigating Vulnerable Atheroma Using Combined 18F-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation , 2011, The Journal of Nuclear Medicine.

[64]  M. Bennett,et al.  Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. , 2011, JACC. Cardiovascular imaging.

[65]  Agnes Pasquet,et al.  Imaging the vulnerable plaque. , 2011, Journal of the American College of Cardiology.

[66]  Matthias Nahrendorf,et al.  Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic , 2011, Circulation research.

[67]  C. Boy,et al.  68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[68]  Peter Carmeliet,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[69]  G. Karcher,et al.  Arterial Foci of F-18 Fluorodeoxyglucose Are Associated With an Enhanced Risk of Subsequent Ischemic Stroke in Cancer Patients: A Case-Control Pilot Study , 2011, Clinical nuclear medicine.

[70]  A. Tawakol,et al.  Imaging of Coronary Inflammation with FDG-PET: Feasibility and Clinical Hurdles , 2011, Current cardiology reports.

[71]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[72]  Z. Fayad,et al.  Imaging of atherosclerosis. , 2011, Annual review of medicine.

[73]  Sungeun Kim,et al.  Vascular Inflammation Stratified by C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels: Analysis with 18F-FDG PET , 2011, The Journal of Nuclear Medicine.

[74]  Hiroshi Takahashi,et al.  Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. , 2010, Clinical therapeutics.

[75]  J. Baron,et al.  Carotid Plaque Inflammation Is Associated With Cerebral Microembolism in Patients With Recent Transient Ischemic Attack or Stroke: A Pilot Study , 2010, Circulation. Cardiovascular imaging.

[76]  A. Davies,et al.  Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. , 2010, Journal of the American College of Cardiology.

[77]  V. Fuster,et al.  The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives. , 2010, American heart journal.

[78]  V. Fuster,et al.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? , 2010, Journal of the American College of Cardiology.

[79]  E. Warburton,et al.  Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis , 2010, Atherosclerosis.

[80]  K. Någren,et al.  Uptake of 11C-Choline in Mouse Atherosclerotic Plaques , 2010, Journal of Nuclear Medicine.

[81]  Ahmed Tawakol,et al.  Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. , 2010, JACC. Cardiovascular imaging.

[82]  M. Reiser,et al.  Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[83]  H. Sillesen,et al.  18FDG PET and ultrasound echolucency in carotid artery plaques. , 2010, JACC. Cardiovascular imaging.

[84]  Sungeun Kim,et al.  Vascular Inflammation in Patients With Impaired Glucose Tolerance and Type 2 Diabetes: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography , 2010, Circulation. Cardiovascular imaging.

[85]  M. D. de Winther,et al.  Macrophage heterogeneity: relevance and functional implications in atherosclerosis. , 2010, Current vascular pharmacology.

[86]  H. Sillesen,et al.  Gene expression and 18FDG uptake in atherosclerotic carotid plaques , 2010, Nuclear medicine communications.

[87]  M. Reiser,et al.  In Vivo Imaging of Macrophage Activity in the Coronary Arteries Using 68Ga-DOTATATE PET/CT: Correlation with Coronary Calcium Burden and Risk Factors , 2010, Journal of Nuclear Medicine.

[88]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[89]  V. Fuster,et al.  Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. , 2009, Atherosclerosis.

[90]  C. Garlanda,et al.  Macrophage diversity and polarization in atherosclerosis: a question of balance. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[91]  M. Reiser,et al.  18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease , 2009, Journal of Nuclear Medicine.

[92]  R. Virmani,et al.  Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. , 2009, Journal of the American College of Cardiology.

[93]  H. Sillesen,et al.  Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[94]  O. Schober,et al.  Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[95]  J. Wassélius,et al.  FDG-Accumulating Atherosclerotic Plaques Identified with 18F-FDG-PET/CT in 141 Patients , 2009, Molecular Imaging and Biology.

[96]  O. Schober,et al.  List Mode–Driven Cardiac and Respiratory Gating in PET , 2009, Journal of Nuclear Medicine.

[97]  J. Wykrzykowska,et al.  Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation , 2009, Journal of Nuclear Medicine.

[98]  G. Kolodny,et al.  Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study , 2009, Nuclear medicine communications.

[99]  V. Fuster,et al.  Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study , 2009, Circulation. Cardiovascular imaging.

[100]  J. Wassélius,et al.  Time-to-time correlation of high-risk atherosclerotic lesions identified with [18F]-FDG-PET/CT , 2009, Annals of nuclear medicine.

[101]  G. Hankey,et al.  Effect of Long-Term Homocysteine Reduction with B Vitamins on Arterial Wall Inflammation Assessed by Fluorodeoxyglucose Positron Emission Tomography: A Randomised Double-Blind, Placebo-Controlled Trial , 2009, Cerebrovascular Diseases.

[102]  G. Dolivet,et al.  Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[103]  E. Warburton,et al.  Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods , 2009, Stroke.

[104]  J. Murabito,et al.  Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. , 2008, European heart journal.

[105]  B. Bendok.  Molecular imaging of inflammation: a successful model in stroke. , 2008, Neurosurgery.

[106]  M. Imaizumi,et al.  Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [(3)H]PK 11195. , 2008, Atherosclerosis.

[107]  C. Apovian,et al.  Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese Subjects , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[108]  Christopher E. Clarke.  A Question of Balance , 2008 .

[109]  Mathias Prokop,et al.  Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. , 2008, The American journal of cardiology.

[110]  Eun Jeong Lee,et al.  Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction , 2008, Journal of Nuclear Medicine.

[111]  Sameer Bansilal,et al.  Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.

[112]  Mathijs Groeneweg,et al.  Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. , 2008, Journal of the American College of Cardiology.

[113]  Marc Faraggi,et al.  Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[114]  A. Alavi,et al.  FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[115]  R. Vasan,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[116]  H. Schild,et al.  Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans—first results , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[117]  V. Fuster,et al.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. , 2007, Journal of the American College of Cardiology.

[118]  P. Calder,et al.  Glucose metabolism in lymphoid and inflammatory cells and tissues , 2007, Current opinion in clinical nutrition and metabolic care.

[119]  A. Arauz,et al.  Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography Pilot study , 2007, Clinical Neurology and Neurosurgery.

[120]  J. Machac,et al.  Simvastatin and plaque inflammation. , 2007, Journal of the American College of Cardiology.

[121]  T. Imaizumi,et al.  Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. , 2007, Journal of the American College of Cardiology.

[122]  A. Balbarini,et al.  Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages , 2007, Journal of leukocyte biology.

[123]  J. Jeng,et al.  Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[124]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[125]  Masatoshi Ishibashi,et al.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.

[126]  Ora Israel,et al.  Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[127]  Shmuel Einav,et al.  A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps , 2006, Proceedings of the National Academy of Sciences.

[128]  J. Borén,et al.  Hypoxia Converts Human Macrophages Into Triglyceride-Loaded Foam Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[129]  G. Mancia,et al.  Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. , 2006, European heart journal.

[130]  R. Virmani,et al.  Pathology of the Vulnerable Plaque , 2006 .

[131]  Erling Falk,et al.  Pathogenesis of atherosclerosis. , 2006, Journal of the American College of Cardiology.

[132]  J. Camm,et al.  [Guidelines on the management of stable angina pectoris: executive summary]. , 2006, Giornale italiano di cardiologia.

[133]  B. Weber,et al.  18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[134]  Martin J Graves,et al.  Identification of Culprit Lesions After Transient Ischemic Attack by Combined 18F Fluorodeoxyglucose Positron-Emission Tomography and High-Resolution Magnetic Resonance Imaging , 2005, Stroke.

[135]  Chun Yuan,et al.  In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.

[136]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[137]  A. Freiman,et al.  Association of vascular 18F-FDG uptake with vascular calcification. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[138]  S. Atkin,et al.  Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium , 2005, British Journal of Cancer.

[139]  Ora Israel,et al.  Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[140]  S. Achilefu,et al.  Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. , 2003, American journal of physiology. Endocrinology and metabolism.

[141]  S. Grundy.  Obesity, metabolic syndrome, and coronary atherosclerosis. , 2002, Circulation.

[142]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[143]  M. Fishbein,et al.  Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.

[144]  M. Davies,et al.  Relationship Between Coronary Artery Remodeling and Plaque Vulnerability , 2002, Circulation.

[145]  Eric Shade,et al.  Ready for prime time , 2002 .

[146]  N. Tamaki,et al.  FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[147]  R. Virmani,et al.  The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes , 2001, Current opinion in cardiology.

[148]  R. Wahl,et al.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) , 2001, Nuclear medicine communications.

[149]  A. Alavi,et al.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.

[150]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[151]  P. Stella,et al.  Coronary artery disease: arterial remodelling and clinical presentation , 1999, Heart.

[152]  Y. Patel.  Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.

[153]  O. Wiklund,et al.  Evidence of hypoxic areas within the arterial wall in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[154]  G Dunn,et al.  Rationale and design. PRiSM Psychosis Study I. , 1998, The British journal of psychiatry : the journal of mental science.

[155]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[156]  P. Libby,et al.  Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. , 1997, Circulation.

[157]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[158]  M. Gimbrone,et al.  Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[159]  V. Fuster,et al.  Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. , 1996, Circulation.

[160]  J. Kaski,et al.  Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology. , 1995, Circulation.

[161]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[162]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[163]  J. A. Painter,et al.  Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. , 1995, Journal of the American College of Cardiology.

[164]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[165]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[166]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[167]  P. Libby,et al.  Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.

[168]  Josiahn . Wilcox,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[169]  A. Maseri,et al.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.

[170]  W. Santamore,et al.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.

[171]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[172]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[173]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[174]  R. Ross,et al.  Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .

[175]  H. J. Yoo,et al.  F-Fluorodeoxyglucose Positron Emission Tomography , 2011 .

[176]  L. Badimón,et al.  Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. , 2009, Frontiers in bioscience.

[177]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[178]  K. Någren,et al.  Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[179]  H. C. Stary.  Composition and classification of human atherosclerotic lesions , 2005, Virchows Archiv A.

[180]  Abass Alavi,et al.  Guest editorial: the conception of FDG-PET imaging. , 2002, Seminars in nuclear medicine.

[181]  P. Libby,et al.  Cytokines as mediators of vascular pathology. , 1992, Nouvelle revue francaise d'hematologie.

[182]  P. Myllynen,et al.  A RANDOMISED CLINICAL TRIAL , 1989 .